Get in line: developing in-process analytical tools for gene therapy applications

René Gantier

Director of Technology for Gene Therapy, Repligen

René Gantier is the Director of Technology for Gene Therapy at Repligen. He has almost 20 years of experience developing production and purification processes for biotherapies. René holds a MSc in Cell Biology from the University of Nantes (France) and a PhD in Biochemistry from the University of Rouen (France). He started his career in the biotechnology industry as a scientist developing long-lasting therapeutic cytokines at Nautilus Biotech (France), before joining Pall Life Sciences as a downstream processing field application specialist, and then expanded his role to lead the Biotech Process R&D team developing end-to-end upstream-downstream continuous bioprocessing solutions for mAbs and cell/gene therapies. In his current role at Repligen, he provides technology guidance to develop high productivity next generation gene therapy manufacturing processes.

Ramsey Shanbaky

Bioprocess Applications Manager, C Technologies Inc. - a Repligen Company

Ramsey Shanbaky is the Bioprocess Applications Manger for C Technologies, Inc. He spent the first 8 years of his career working in R&D, Manufacturing and Product Management designing and building fiber optic products for high powered laser delivery in the medical device industry. In the first part of his tenure at C Technologies, he worked alongside his customers to implement the SoloVPE product with biopharmaceutical accounts primarily in the western region. For the last 5 years, he has been partnering with customers to implement the FlowVPE system for inline concentration measurements both in the process development areas and GMP manufacturing areas for bioprocessing. He holds an BSEE from Purdue University and multiple patents and applications.

Jay West

Principal Scientist at Bristol Myers Squibb

Jay West is Principal Scientist at Bristol Myers Squibb in the Process Development Analytics group in Devens, MA. He obtained his BS in Chemistry from Rensselaer, MS in Chemistry from University at Albany, PhD in Biochemistry from Boston College, and performed postdoctoral research at Northeastern University. He has 8 years pharmaceutical industry experience, having worked at Regeneron Pharmaceuticals precious to BMS. His focus the past three years has been on Process Analytical Technology, particularly in downstream process development.